Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patients Living with Chronic Illness

Thomas R. Collins  |  December 5, 2022

PHILADELPHIA—Amy Gietzen started feeling the pain when she was 19. Her forearms, elbows, wrists and fingers were constantly swollen and sensitive. Six months later, she saw a doctor and was diagnosed with systemic diffuse scleroderma—a particularly hard-to-manage rheumatic disease with wide-ranging effects.

Amy Gietzen

Ms. Gietzen, who spoke at ACR Convergence 2022 and is a public speaker, patient advocate and writer, gave testimony on the profound life change that the disease wrought and about the transformation that can happen with well-executed collaborative care. She and two other people with rheumatic diseases shared their experience and the avenues they’ve found to cope—and that have, along the way, boosted others as well.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After her diagnosis, Ms. Gietzen, who lives in Buffalo, N.Y., was soon diagnosed with interstitial lung disease, hypertension and heart complications.

“My skin became hard and tight, my hands contracted inward, causing fingertip sores and ulcerations, which ultimately led to me having some self-amputations of my fingertips,” she said. “My experience with doctors, more specifically scleroderma specialists, was extremely limited locally.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“I felt lost and almost out of control, like my disease was overtaking my body, like I couldn’t catch a break,” she added.

Finding a Care Team

Her eyes opened, she said, when she was asked in 2016 to participate in a patient-centric interprofessional event (IPE) through the Ann Steffens Scleroderma Foundation in which patients would help educate an array of medical professionals—nurses, pharmacists, physical therapists—about scleroderma. This kind of team was what she’d been yearning for.

Eventually, she managed to find a scleroderma collaborative care team of her own.

“Once I did that, it felt like I was coming home—it changed the trajectory of disease,” said Ms. Gietzen, who writes a column about her experiences called “Staying Alive with Scleroderma.”

In 2019, she had a heart event and needed an implantable cardioverter defibrillator.

“As time passed, my symptoms were monitored by highly trained scleroderma professionals,” she said. “They provided continual communication through multiple doctor assessments, offering a keen sense of security.”

This approach, she said, “gave me complete confidence in my team and it allowed me to take an active role, which boosted my confidence even more.”

She said she felt a deep sense of renewal once her care became comprehensive and open to her input and involvement.

“Finding my care team gave me hope,” she said, “that there is a way to gain back the life that scleroderma took from me, that I can take an active role in decision making, that I can take my control back.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsPatient Perspective Tagged with:ACR Convergence 2022

Related Articles

    Patients Fight Against Dark Days & Find Ways to Cope

    December 2, 2022

    PHILADELPHIA—Amy Gietzen started feeling the pain when she was 19. Her forearms, elbows, wrists and fingers were constantly swollen and sensitive. Six months later, she saw a doctor and was diagnosed with systemic diffuse scleroderma—a particularly hard-to-manage rheumatic disease with wide-ranging effects. Ms. Gietzen, who spoke at ACR Convergence 2022 and is a public speaker,…

    Juvenile Arthritis Camps Offer Kids Freedom, Fun & Education

    October 18, 2018

    With the wind in her hair and a smile on her face, a young girl flies through the air on the zip line at Camp Wekandu. She waves to her fellow campers on the ground and offers a thumbs up before the ride ends and one of the camp counselors lowers her from the zip…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences